J Richard Evanson, DO
Orthopaedic Surgery · Plano, TXNPI 1003072604
Payments from drug & device makers
Across 173 payments — averaging $46,705 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$7.9M
- Takeda Pharmaceuticals U.S.A., Inc.$104K
- Stryker$39K
- Endo Pharmaceuticals Inc.$25K
- Pacira Pharmaceuticals Incorporated$2K
- Johnson & Johnson$220
- plus $872 from 18 others
What the payments were for
- Consulting fees$30,70476%
- Travel & lodging$2,1725%
- Food & beverage$7,50319%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 15 | $7,908,901 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $103,993 |
| Stryker | 100 | $39,272 |
| Endo Pharmaceuticals Inc. | 6 | $25,078 |
| Pacira Pharmaceuticals Incorporated | 1 | $1,671 |
| Johnson & Johnson | 9 | $220 |
| Smith+Nephew | 6 | $125 |
| Medical Device Business Services, Inc. | 2 | $115 |
| Bioventus LLC | 3 | $86 |
| Innovation Technologies Inc | 4 | $84 |
| Heron Therapeutics, Inc. | 1 | $80 |
| Vericel Corporation | 1 | $68 |
| Pylant Medical | 1 | $50 |
| Amgen | 3 | $45 |
| Medacta USA, Inc. | 2 | $44 |
| Orthofix Medical, Inc. | 1 | $31 |
| Axogen | 1 | $25 |
| Baudax Bio Inc. | 1 | $22 |
| Zimmer Biomet | 1 | $22 |
| Moximed, Inc | 1 | $21 |
| Medtronic | 1 | $18 |
| Si-bone, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Molnlycke Health Care US, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,080,007 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 450 | $1,277 |
| Cephalexin | 96 | $1,218 |
| Gabapentin | 195 | $941 |
| Omeprazole | 98 | $474 |
| Oxycodone Hcl | 138 | $438 |
| Celecoxib | 13 | $398 |
| Promethazine Hcl | 70 | $375 |
| Naproxen | 20 | $318 |
| Tizanidine Hcl | 28 | $130 |
| Amoxicillin | 72 | $98 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Plano
- Isador LiebermanPlano$1.3M
- Jack ZiglerPlano$1.2M
- Gerhard MaalePlano$1.1M
- Michael SchwartzPlano$993K
- Cyrus AbbaschianPlano$749K
- Khalid YousufPlano$485K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Stefan KreuzerHouston$7M
- Robert GrahamAustin$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.